论文信息 - Treatment of relapsed or refractory non-hodgkin lymphoma with the oral isotype-selective histone deacetylase inhibitor MGCD0103: Interim results from a phase II study - 字舞流文

Treatment of relapsed or refractory non-hodgkin lymphoma with the oral isotype-selective histone deacetylase inhibitor MGCD0103: Interim results from a phase II study

R. Martell | M. Crump | D. Rizzieri | C. Andreadis | Zuomei Li | A. Younes | S. Assouline | P. McLaughlin | E. Laille | A. Wedgwood | P. Mclaughlin